Cargando…
Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future
Atherosclerotic cardiovascular disease is the most common cause of morbidity and death worldwide. Recent studies have demonstrated that this chronic inflammatory disease of the arterial wall can be controlled through the modulation of immune system activity. Many patients with cardiovascular disease...
Autores principales: | Lecis, Dalgisio, Massaro, Gianluca, Benedetto, Daniela, Di Luozzo, Marco, Russo, Giulio, Mauriello, Alessandro, Federici, Massimo, Sangiorgi, Giuseppe Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342012/ https://www.ncbi.nlm.nih.gov/pubmed/37446157 http://dx.doi.org/10.3390/ijms241310979 |
Ejemplares similares
-
Clinical Features and Management of COVID-19–Associated Hypercoagulability
por: Massaro, Gianluca, et al.
Publicado: (2022) -
Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time?
por: Bonanni, Michela, et al.
Publicado: (2022) -
Current Options and Future Perspectives in the Treatment of Dyslipidemia
por: Muscoli, Saverio, et al.
Publicado: (2022) -
Successful percutaneous catheter-directed treatment of high-risk pulmonary embolism: a case report
por: Russo, Debora, et al.
Publicado: (2023) -
Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future
por: Schüller, Simone S., et al.
Publicado: (2018)